United Asset Strategies’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-37,418
| Closed | -$1.72M | – | 216 |
|
|
2020
Q4 | $1.72M | Buy |
37,418
+807
| +2% | +$37.1K | 0.27% | 76 |
|
|
2020
Q3 | $1.72M | Sell |
36,611
-2,147
| -6% | -$101K | 0.32% | 71 |
|
|
2020
Q2 | $1.98M | Sell |
38,758
-3,786
| -9% | -$193K | 0.39% | 64 |
|
|
2020
Q1 | $2.02M | Sell |
42,544
-348
| -0.8% | -$16.5K | 0.5% | 52 |
|
|
2019
Q4 | $2.52M | Sell |
42,892
-4,077
| -9% | -$239K | 0.49% | 61 |
|
|
2019
Q3 | $2.51M | Buy |
46,969
+10,599
| +29% | +$566K | 0.55% | 58 |
|
|
2019
Q2 | $1.82M | Buy |
36,370
+3,343
| +10% | +$167K | 0.42% | 71 |
|
|
2019
Q1 | $1.73M | Sell |
33,027
-3,052
| -8% | -$159K | 0.41% | 68 |
|
|
2018
Q4 | $1.72M | Buy |
36,079
+27,601
| +326% | +$1.32M | 0.47% | 61 |
|
|
2018
Q3 | $426K | Sell |
8,478
-80
| -0.9% | -$4.02K | 0.1% | 151 |
|
|
2018
Q2 | $431K | Hold |
8,558
| – | – | 0.11% | 151 |
|
|
2018
Q1 | $418K | Buy |
8,558
+80
| +0.9% | +$3.91K | 0.12% | 141 |
|
|
2017
Q4 | $376K | Buy |
+8,478
| New | +$376K | 0.1% | 148 |
|
|
2016
Q2 | – | Sell |
-8,958
| Closed | -$454K | – | 141 |
|
|
2016
Q1 | $454K | Buy |
8,958
+3
| +0% | +$152 | 0.2% | 83 |
|
|
2015
Q4 | $452K | Buy |
+8,955
| New | +$452K | 0.2% | 91 |
|
|
2015
Q2 | – | Sell |
-8,949
| Closed | -$516K | – | 132 |
|
|
2015
Q1 | $516K | Sell |
8,949
-474
| -5% | -$27.3K | 0.24% | 80 |
|
|
2014
Q4 | $503K | Buy |
9,423
+3
| +0% | +$160 | 0.22% | 84 |
|
|
2014
Q3 | $541K | Buy |
9,420
+512
| +6% | +$29.4K | 0.24% | 82 |
|
|
2014
Q2 | $596K | Buy |
8,908
+962
| +12% | +$64.4K | 0.29% | 76 |
|
|
2014
Q1 | $531K | Buy |
7,946
+198
| +3% | +$13.2K | 0.3% | 68 |
|
|
2013
Q4 | $517K | Hold |
7,748
| – | – | 0.36% | 61 |
|
|
2013
Q3 | $486K | Hold |
7,748
| – | – | 0.31% | 66 |
|
|
2013
Q2 | $484K | Buy |
+7,748
| New | +$484K | 0.32% | 69 |
|